PTPRC and acute myeloid leukemia: At the time of sacrifice the BM of HDC-treated mice transplanted with WT AML cells contained significantly fewer CD45+ leukemic cells, compared to control-treated mice (32 ± 21 vs. 7 ± 13 of all hematopoietic cells, median ± SD).